• 戒撸（每日签到）破解版-快鸭加速器

    Uniting stakeholders to share knowledge, foster collaboration, enable solutions and expand support critical to the development of—and future access to—an HIV vaccine

    Learn moreStrategic Plan
    Diagram of the plan

A renewed Strategic Plan

Uniting stakeholders to share knowledge, foster collaboration, enable solutions and to support the most critical issues, risks and challenges faced by the field

Increasing resources

Mobilizing new funding to support and grow the field of HIV vaccine research and development

赛·风4 for android

Promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts

戒撸（每日签到）破解版-快鸭加速器

戒撸（每日签到）破解版-快鸭加速器

/in News /by

With over 600 virtual sessions and events, AIDS 2024: Virtual will enable delegates to access and engage with the latest HIV science, advocacy and knowledge traditionally presented at the conference, while offering a range of new features made possible by the new virtual format. Biomedical prevention interventions have saved lives and helped prevent new HIV infections. However, declines in incidence remain far from UNAIDS targets. A safe and globally effective HIV vaccine remains a necessity for a durable control and end to the epidemic. Download the HIV vaccine, and vaccine research roadmap.

Read more

戒撸（每日签到）破解版-快鸭加速器

戒撸（每日签到）破解版-快鸭加速器

/in Events /by

This scientific and technical workshop aims to continue from the first HIV Prevention Efficacy Trial Designs of the Future symposium, held in November 2018 in Seattle by the Fred Hutch and the NIAID. Participants will reflect on more recent advances and challenges within the HIV prevention field and on the rationale and lessons learned for current HIV prevention designs.

Read more

戒撸（每日签到）破解版-快鸭加速器

In 2012, the Enterprise launched Timely Topics in HIV Vaccines, a strategy series convening experts as rapidly as possible to analyze, address, and respond to unresolved and emerging priority issues in the field. Through an open call for proposals, the Enterprise is working to identify the most important strategic needs of the field and sponsoring think tanks, meetings, forums and other events to tackle these issues.
Submit a timely topic

戒撸（每日签到）破解版-快鸭加速器

C. Bickel, Science Translational Medicine; National Institute of Allergy and Infectious Diseases

戒撸（每日签到）破解版-快鸭加速器

Book case (illustration)

戒撸（每日签到）破解版-快鸭加速器

African children (illustration)

2nd Infant Trials Workshop

賽风官网下载

Knowns and Unknowns of Assaying ADCC against HIV

戒撸（每日签到）破解版-快鸭加速器

Sign up to receive the latest news of the Vaccine Enterprise and occasional information related to IAS activities related to vaccine research and development (Please read our Privacy Policy)

© Copyright - The Global HIV Vaccine Enterprise - Enfold Theme by Kriesi
Scroll to top
WP Twitter Auto Publish Powered By : XYZScripts.com